Td Ameritrade Investment Management, LLC Biogen Inc. Transaction History

Td Ameritrade Investment Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	SELL	$187.54 - $223.02 $33,194 - $39,474	-177 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$193.77 - $244.14 $581 - $732	-3 Reduced 1.67%	177 $37,000
Q4 2021 Feb 11, 2022	BUY	$223.92 - $287.77 $40,305 - $51,798	180 New	180 $43,000
Q1 2020 May 13, 2020	SELL	$268.85 - $341.04 $36,563 - $46,381	-136 Closed	0 $0
Q4 2019 Feb 07, 2020	BUY	$220.06 - $304.07 $1,320 - $1,824	6 Added 4.62%	136 $40,000
Q2 2019 Aug 13, 2019	BUY	$219.29 - $241.72 $28,507 - $31,423	130 New	130 $30,000
Q1 2019 May 15, 2019	SELL	$216.71 - $338.96 $2,383 - $3,728	-11 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$278.5 - $352.75 $1,949 - $2,469	7 Added 175.0%	11 $3,000
Q3 2018 Nov 14, 2018	BUY	$293.51 - $383.83 $1,174 - $1,535	4 New	4 $1,000

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Td Ameritrade Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Td Ameritrade Investment Management, LLC with notifications on news.